Showing 1 - 6 results of 6 for search 'Jonsson, M', query time: 0.03s
Refine Results
-
1
Application of Human Stem Cell−derived Cardiomyocytes in Safety Pharmacology Requires Caution Beyond hERG by Jonsson, M, Vos, M, Mirams, G, Duker, G, Sartipy, P, de Boer, T, van Veen, T
Published 2012Journal article -
2
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG by Jonsson, M, Vos, M, Mirams, G, Duker, G, Sartipy, P, De Boer, T, Van Veen, T
Published 2012Journal article -
3
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. by Jonsson, M, Vos, M, Mirams, G, Duker, G, Sartipy, P, de Boer, T, van Veen, T
Published 2012Journal article -
4
-
5
Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years. by Sooriakumaran, P, Haendler, L, Nyberg, T, Gronberg, H, Nilsson, A, Carlsson, S, Hosseini, A, Adding, C, Jonsson, M, Ploumidis, A, Egevad, L, Steineck, G, Wiklund, P
Published 2012Journal article -
6
The impact of length and location of positive margins in predicting biochemical recurrence after robot-assisted radical prostatectomy with a minimum follow-up of 5 years. by Sooriakumaran, P, Ploumidis, A, Nyberg, T, Olsson, M, Akre, O, Haendler, L, Egevad, L, Nilsson, A, Carlsson, S, Jonsson, M, Adding, C, Hosseini, A, Steineck, G, Wiklund, P
Published 2015Journal article